COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
Discussion
Overall, the MS cohort had a risk of severe events that is twice the risk than the age- and sex-matched Italian population. This excess of risk is mainly explained by the EDSS score and comorbidities, whereas a residual increase of hospitalization risk was observed in patients on anti-CD20 therapies and a decrease in people on interferon.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Sormani, M. P., Schiavetti, I., Carmisciano, L., Cordioli, C., Filippi, M., Radaelli, M., Immovilli, P., Capobianco, M., De Rossi, N., Brichetto, G., Cocco, E., Scandellari, C., Cavalla, P., Pesci, I., Zito, A., Confalonieri, P., Marfia, G. A., Perini, P. Tags: COVID-19, Multiple sclerosis, Incidence studies, Risk factors in epidemiology Article Source Type: research
More News: Brain | COVID-19 | Disability | Epidemiology | Intensive Care | Italy Health | Multiple Sclerosis | Neurology | PET Scan | Study